GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Purchase Of Business

Psyence Biomedical (Psyence Biomedical) Purchase Of Business : $ Mil (TTM As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Purchase Of Business?

Psyence Biomedical's purchase of business for the six months ended in Mar. 2023 was $0.00 Mil. It means Psyence Biomedical spent $0.00 Mil on purchasing business.

Compared with last quarter ($0.00 Mil in Mar. 2022 ), Psyence Biomedical spent the same money on purchasing business in Mar. 2023 ($0.00 Mil).

Psyence Biomedical Purchase Of Business Historical Data

The historical data trend for Psyence Biomedical's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Purchase Of Business Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Purchase Of Business
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Purchase Of Business - - -

Psyence Biomedical Purchase Of Business Calculation

The amount used to purchase business.

Psyence Biomedical Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Purchase Of Business
Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Website
https://www.psyence.com
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024